Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183K Sell
4,289
-107
-2% -$4.78K 0.01% 1331
2026
Q1
$212K Sell
4,396
-662
-13% -$30.9K 0.01% 1074
2025
Q4
$245K Buy
5,058
+264
+6% +$13.1K 0.01% 892
2025
Q3
$226K Sell
4,794
-907
-16% -$43.8K 0.01% 890
2025
Q2
$275K Sell
5,701
-356
-6% -$18.2K 0.02% 717
2025
Q1
$336K Buy
6,057
+2,241
+59% +$121K 0.03% 555
2024
Q4
$184K Sell
3,816
-816
-18% -$41.5K 0.02% 731
2024
Q3
$267K Buy
4,632
+1,569
+51% +$84.7K 0.03% 505
2024
Q2
$149K Buy
3,063
+944
+45% +$45.5K 0.02% 600
2024
Q1
$103K Buy
2,119
+495
+30% +$24.2K 0.02% 640
2023
Q4
$81K Buy
+1,624
New +$79.4K 0.02% 631

Other funds holding SNY

GAMMA Investing's SNY Position: Q2 2026 in Review

GAMMA Investing reduced its Sanofi (SNY) stake by 2.4% in Q2 2026, selling an estimated $4.78K and leaving 4,289 shares worth $183K. The position accounts for 0.01% of the portfolio, ranked #1331.

GAMMA Investing first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $336K in Q1 2025. 101 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • GAMMA Investing held 4,289 shares of Sanofi worth $183K as of Q2 2026.
  • GAMMA Investing sold 107 Sanofi shares in Q2 2026, an estimated $4.78K.
  • Sanofi made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1331 holding.
  • GAMMA Investing first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Sanofi position peaked at $336K in Q1 2025.
  • 101 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.